Seeking Alpha46m
Hims & Hers: Brace For Impact As It Faces A Possible 18% Revenue Hit
Hims & Hers Health, Inc. (NYSE:HIMS) stock tanked around 26% on Friday after the U.S. FDA announced that the shortage of semaglutide injection products has been resolved. Data by YCharts Semaglutide ...
Why Hims & Hers Health, Inc. (HIMS) Went Down on Tuesday
We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money ...
Hims and Hers Health call volume above normal and directionally bullish
Bullish option flow detected in Hims and Hers Health with 68,147 calls trading, 3x expected, and implied vol increasing almost 3 points to ...
Hosted on MSN8h
Wall Street's Most Wanted: 2 Highly Shorted Stocks Right Now
Short-selling is an interesting part of the stock market that can be dangerous and even controversial. Investors selling ...
Hims & Hers price target raised to $44 from $28 at TD Cowen
TD Cowen raised the firm’s price target on Hims & Hers to $44 from $28 and keeps a Buy rating on the shares. The firm continues to believe ...
UK stock investors are piling into this under-the-radar share up 270%! Should I join them?
This writer noticed that UK stock investors have been buying an obscure share that fell 26% yesterday but is still up nearly ...
Hims & Hers Health, Inc.: Jim Cramer Warns ‘The Gravy Train Might Be Over’ After FDA’s Ozempic Update
We recently published a list of Jim Cramer on 10 Stocks With The Biggest Declines Last Week. In this article, we are going to ...